PathogenDx
PathogenDx develops proprietary D3 Array microarray technology for rapid, multiplexed pathogen detection. The Scottsdale-based company serves cannabis testing laboratories, food safety and poultry processors, and clinical diagnostics customers through diagnostic kits, automation equipment, and cloud-based software.
- Company typePrivate
- Founded2014
- HeadquartersScottsdale, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What PathogenDx does
PathogenDx is a Scottsdale, Arizona-based molecular diagnostics company founded in 2014 that has developed a proprietary microarray technology platform called D3 Array (Dynamic Dimensional Detection) for rapid, multiplexed pathogen detection. The core technology features a three-dimensional cross-linked porous structure that enables room temperature hybridization and detection of up to 100+ targets in a single reaction with single-gene copy sensitivity, positioning the platform between traditional qPCR (limited multiplexing) and NGS (high cost and slow turnaround). The company serves laboratories, food processors, poultry producers, and clinical facilities across three primary verticals: cannabis and hemp testing (the core market with 120+ lab partnerships across 36 US states), food safety and poultry processing, and clinical diagnostics.
PathogenDx generates revenue primarily through one-time sales of diagnostic testing kits and assays—including DetectX Combined, QuantX Fungal, QuantX Bacterial, SeroX, SalSure, SalVac, PhytoX, and D3 Array-UTI—complemented by hardware sales of the Octa AutoPrep Station and subscription-based cloud data reporting software. Distribution is primarily direct enterprise sales with technical webinars and demonstrations, supplemented by channel partnerships including Axiology Labs for international distribution in Africa and Thailand. Multiple AOAC Performance Tested Method certifications across the assay portfolio provide regulatory credibility in compliance-driven testing markets, and the company holds ISO 9001:2015 quality management certification.
The company has raised approximately $11.6M across three funding rounds from 2016 through 2019, with investors including Altitude Investment Management, Cresco Capital Partners, and Salveo Capital—many with cannabis industry exposure. Recent strategic activity includes launching the Unified Salmonella Testing System at IPPE 2026 for poultry processors, entering clinical diagnostics with D3 Array-UTI, expanding internationally via Axiology Labs, and scaling the executive team with new sales, R&D, and advisory leadership.
PathogenDx firmographics
Firmographics- Name
- PathogenDx
- Legal name
- PathogenDx Corporation
- Website
- https://pathogendx.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PathogenDx develops proprietary D3 Array microarray technology for rapid, multiplexed pathogen detection. The Scottsdale-based company serves cannabis testing laboratories, food safety and poultry processors, and clinical diagnostics customers through diagnostic kits, automation equipment, and cloud-based software.
- Ownership category
- akta.pro rank
PathogenDx industry classification
Industry- Product category
- Molecular Diagnostic Testing
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
- akta.pro secondary industries
- Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Multiplex Syndromic POCT Panels (Respiratory/GI/meningitis panels) (HLAHAOAJ), Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Risk Assessment, Hazard Analysis & Food Defense/Fraud Programs (AFALAAAO), Pathogen & Disease Diagnostics Services (Plant, Soil, Water) (AFACAKAG), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)
Keywords
Where PathogenDx is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
PathogenDx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Diagnostic Testing Kits: Sale of specialized pathogen detection assays including bacterial, fungal, and viral testing kits for cannabis, food safety, agriculture, and clinical applications. Products include DetectX Combined, QuantX Fungal, QuantX Bacterial, SeroX, SalSure, SalVac, PhytoX, and D3 Array-UTI.
- Automation Equipment: Sale of Octa AutoPrep Station and related automation equipment for sample preparation, enabling laboratories to streamline workflows and reduce labor costs.
- Software & Cloud Services: Cloud-based data reporting and automated report generation software for analysis, quantification, and result management.
- Technical Support & Services: Technical support services including phone support (800-641-2102), email support, and technical webinars for product implementation and training.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Testing kits and assays sold with pricing based on volume and specific assay requirements |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
PathogenDx product offering
Product offeringCore offering
PathogenDx develops and sells multiplexed pathogen detection testing kits, automated sample preparation hardware, and cloud-based analysis software built on its proprietary D3 Array microarray platform. Its products rapidly and accurately detect bacterial, fungal, and viral pathogens for cannabis testing laboratories, food safety and poultry producers, agricultural testing facilities, and clinical diagnostic laboratories.
Product overview
PathogenDx offers a unified suite of pathogen testing solutions built on its proprietary D3 Array™ microarray technology platform. The core D3 Array™ technology provides three-dimensional molecular binding architecture enabling rapid, highly multiplexed detection of bacterial, fungal, and viral pathogens. The product portfolio spans clinical diagnostics (D3 Array™-UTI for urinary tract infections), food safety testing (SalSure, SeroX, SalVac for Salmonella detection and serotyping), and agricultural testing (DetectX Combined, QuantX Fungal, QuantX Bacterial, PhytoX for cannabis/hemp and plant virus detection). Supporting hardware includes the Octa™ AutoPrep Station for automated sample preparation. All assays leverage the same core D3 Array™ platform architecture, allowing shared sample preparation and delivering results in a single lab shift without enrichment requirements.
Differentiator
Problem solved
Functional benefit
Brands
- D3 Array: Dynamic Dimensional Detection Array technology - proprietary multiplexed molecular testing platform for pathogen detection
- DetectX Combined
- QuantX Fungal
- QuantX Bacterial
- SeroX
- SalSure
- SalVac
- Octa AutoPrep Station
- PhytoX
- EnviroX
Products and services
- D3 Array Technology Platform Proprietary microarray technology platform featuring a three-dimensional cross-linked porous structure that enables rapid, multiplexed pathogen detection with up to 400+ unique probes per well and single gene copy sensitivity. Used as the foundation for all PathogenDx assays.
- D3 Array-UTI Fast multiplexed testing solution for urinary pathogen detection running simultaneously with antibiotic resistance gene markers, identifying 26 causative pathogens and 12 antibiotic resistance genes in a single test with results in under 6.5 hours. For clinical laboratories.
- DetectX Combined AOAC-certified testing technology enabling simultaneous detection of bacterial and fungal pathogens in a single reaction, single well, single array, delivering comprehensive results in a single lab shift with 65% cost savings. For cannabis and hemp testing laboratories.
- QuantX Fungal Semi-quantitative assay for fungal species quantification in total yeast and mold testing, providing results in a single shift with PTM certification for TYM from 100-100,000 CFU/g. For cannabis testing laboratories.
- QuantX Bacterial Semi-quantitative assay combining analysis of four broad class bacterial indicators (Total Aerobic Bacteria, Bile Tolerant Gram Negative, Enterobacteriaceae, Coliforms) plus species-specific detection within each class. For cannabis testing laboratories.
- PhytoX RT-PCR microarray assay detecting nine plant viruses including Hop Latent Viroid, Lettuce Chlorosis Virus, Cannabis Cryptic Virus, Beet Curly Top Virus, Tobacco Streak Virus, Arabis Mosaic Virus, Alfalfa Mosaic Virus, Tobacco Mosaic Virus, and Cucumber Mosaic Virus in a single test with results in three hours or less. For agricultural and cannabis testing.
- EnviroX Environmental screening assay for presence or absence of 30+ bacterial and/or fungal pathogens and broad class indicators, usable with food, cannabis, agriculture products, environmental swabs, air sampling, and water sampling.
- Octa AutoPrep Station Automated sample preparation system compatible with all PathogenDx AOAC-certified assays, reducing labor costs by 80%, hands-on time by 1 hour 18 minutes for 96 samples, with a compact 12x18x18 inch lab footprint.
- SeroX Ultra-rapid Salmonella serotyping assay delivering advanced gene detection of Salmonella and all proposed and future USDA FSIS serotypes in a single well reaction at a fraction of the cost and time of conventional methods. For poultry producers and food processors.
- SalSure Detect Rapid, high-confidence detection of Salmonella species from simple carcass rinsate with results in 2 hours, no enrichment required. For poultry processors.
- SalSure Quant Quantitative Salmonella detection providing CFU-level insight for process control in poultry operations. For poultry processors.
- SalVac Multiplexed assay detecting Salmonella spp., wild-type S. Typhimurium, and Megan Vac 1 vaccine with higher sensitivity and specificity than qPCR and other methods. For poultry processors.
- Unified Salmonella Testing System Comprehensive poultry testing system combining SalSure Detect, SalSure Quant, SeroX, and SalVac assays for detection, quantitation, serotyping, and vaccine identification in one scalable approach. For poultry producers and food processors.
Quantifiable outcome
- 80% reduction in labor costs with Octa AutoPrep Station
- +6 more outcomes
Companies that use PathogenDx
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
PathogenDx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
PathogenDx partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Axiology LabscoreAxiology Labs distributes PathogenDx's Clade Variant equipment and testing kits to its lab network across Africa and Thailand. Axiology Labs handles installation, training, support, and service for COVID-19 variant testing products.
- Formula DiagnosticsminorPartnership with Formula Diagnostics (FDX), a clinical laboratory provider, for COVID-19 testing services. FDX provides laboratory testing services while PathogenDx supplies testing technology.
- Bashas' Food CityminorCommunity service partnership bringing COVID-19 testing to uninsured individuals in Phoenix and Mesa, Arizona at no cost. PathogenDx provides testing kits, Formula Diagnostics processes samples.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
PathogenDx competitors and assessment
Company assessmentBroad incumbents
- bioMérieux (BioFire Diagnostics): Global diagnostics incumbent owning BioFire FilmArray, the leading multiplexed syndromic PCR panel. Directly comparable to PathogenDx because BioFire competes in clinical multiplex infectious-disease diagnostics (respiratory, GI, meningitis panels) with the same core value proposition of consolidated, rapid, sample-to-answer testing.
- Becton Dickinson (BD MAX System): BD MAX is an open-architecture molecular platform used by clinical and food-safety labs for syndromic and targeted pathogen panels. Comparable to PathogenDx as a multiplex molecular option for laboratories, with broader menu and larger installed base.
- Cepheid (Danaher, GeneXpert): GeneXpert is the dominant rapid molecular testing platform for clinical infectious disease (including MTB, CT/NG, SARS-CoV-2) and is increasingly being adopted in food safety. Directly comparable to PathogenDx's D3 Array in delivering rapid molecular pathogen detection at the lab bench.
- Hologic (Panther Fusion): Panther Fusion is a fully automated, high-throughput molecular diagnostics platform used for women's health, STI, and respiratory pathogen testing. Comparable to PathogenDx's clinical multiplex roadmap (UTI, STI, sepsis) where Panther Fusion competes on automation and menu breadth.
Direct peers
- Qiagen (QIAstat-Dx): Offers QIAstat-Dx multiplex syndromic panels for respiratory, GI, and meningitis pathogens using a closed-cartridge real-time PCR system. Direct competitor to PathogenDx in clinical and foodborne pathogen detection where multiplex, rapid, single-shift workflows are the buying criterion.
- Neogen Corporation: Major food-safety diagnostics provider offering pathogen detection kits, sanitation monitoring, and culture-based/molecular assays for Salmonella, Listeria, and E. coli in meat, poultry, and produce processors. Direct peer to PathogenDx in food-safety/poultry Salmonella testing and PEM programs.
- Hygiena (EnSure Touch, BAX): Specialist in rapid food and environmental pathogen testing with the BAX System (PCR-based Salmonella/Listeria detection) and ATP hygiene monitoring. Direct competitor to PathogenDx's SalSure, SeroX, EnviroX, and DetectX Food Safety product lines in food-processing labs.
- Medicinal Genomics: Cannabis-specific molecular testing provider for Hop Latent Viroid, aspergillus, and other pathogens via qPCR. Direct competitor to PathogenDx in the cannabis regulatory testing market, particularly for PhytoX and DetectX Combined applications.
Emerging players
- Rheonix: Developer of the fully automated, microarray-based multiplex molecular testing platforms (e.g., STI/Resistance, beer-spoilage detection) with a similar technical approach to PathogenDx's D3 Array. Direct technology peer at smaller scale.
- T2 Biosystems: Developer of T2 Magnetic Resonance-based direct-from-sample diagnostic panels for sepsis (T2Bacteria, T2Candida) and other infectious disease applications. Comparable to PathogenDx as a smaller, emerging multiplex rapid-diagnostics company pursuing clinical pathogen detection.
Market position
Strengths5 records
Weaknesses2 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
PathogenDx social profiles
Digital presencePathogenDx compliance and trust
Trust signalCompliance5 records
PathogenDx financial estimates
Financial estimateRevenue estimate
Valuation estimate
PathogenDx leadership team
Management profileNumber of profiles
Profiles7 records
PathogenDx funding detail
Funding detailFunding overview
Funding rounds3 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PathogenDx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PathogenDx
What does PathogenDx do?
PathogenDx develops and sells multiplexed pathogen detection testing kits, automated sample preparation hardware, and cloud-based analysis software built on its proprietary D3 Array microarray platform. Its products rapidly and accurately detect bacterial, fungal, and viral pathogens for cannabis testing laboratories, food safety and poultry producers, agricultural testing facilities, and clinical diagnostic laboratories.
Is PathogenDx a public or private company?
PathogenDx is a private company. It is classified as venture growth investor backed and is currently operating.
When was PathogenDx founded?
PathogenDx was founded in 2014. It employs 11 to 50 people.
Where is PathogenDx based?
PathogenDx is headquartered in Scottsdale, United States, in the North America region.
How does PathogenDx make money?
Four revenue lines are on record. Diagnostic Testing Kits are the primary driver. The others are automation Equipment, software & Cloud Services and technical Support & Services.
Who are PathogenDx's main competitors?
Broad incumbents on record are bioMérieux (BioFire Diagnostics), Becton Dickinson (BD MAX System), Cepheid (Danaher, GeneXpert) and Hologic (Panther Fusion). Direct peers are Qiagen (QIAstat-Dx), Neogen Corporation, Hygiena (EnSure Touch, BAX) and Medicinal Genomics. Emerging players are Rheonix and T2 Biosystems.
Does PathogenDx have an API?
No public API is recorded for PathogenDx.
What industry is PathogenDx in?
PathogenDx's product category is Molecular Diagnostic Testing. Its primary akta.pro industry code is HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels), with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 325413 and its SIC code is 2835.